Mass-forming pancreatitis with positive fluoro-2-deoxy-D: -glucose positron emission tomography and positive diffusion-weighted imaging-magnetic resonance imaging: Report of a case
- PMID: 19198997
- DOI: 10.1007/s00595-008-3813-8
Mass-forming pancreatitis with positive fluoro-2-deoxy-D: -glucose positron emission tomography and positive diffusion-weighted imaging-magnetic resonance imaging: Report of a case
Abstract
It is difficult to make an accurate radiological diagnosis of a pancreatic tumor because of its location and anatomical characteristics. Mass-forming pancreatitis and pancreatic cancer are particularly difficult to differentiate. New diagnostic technology, which includes diffusion-weighted imaging-magnetic resonance imaging (DWI-MRI) and 2-[(18)F]-fluoro-2-deoxy-Dglucose positron emission tomography (FDG-PET), offers hope for the detection of classical pancreatic cancer. Few studies have been conducted on FDG-PET and DWI-MRI as tools used to distinguish between mass-forming pancreatitis and pancreatic cancers. Furthermore, positive findings of mass-forming pancreatitis on DWI-MRI and FDG-PET have yet to be documented. We report a case of a pancreatic head tumor, present on FDG-PET and DWI-MRI which, on closer examination, revealed benign mass-forming pancreatitis. We discuss the utility of FDG-PET and DWI-MRI as preoperative diagnostic tools.
Similar articles
-
A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa. Ann Surg. 2009. PMID: 19687736
-
Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.Invest Radiol. 2013 May;48(5):247-55. doi: 10.1097/RLI.0b013e31828d56a1. Invest Radiol. 2013. PMID: 23519008
-
Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer.Br J Surg. 1999 Feb;86(2):194-9. doi: 10.1046/j.1365-2168.1999.01016.x. Br J Surg. 1999. PMID: 10100786
-
Diffusion-weighted MRI versus FDG-PET/CT for diagnosing pancreatic cancer: an indirect comparison meta-analysis.Acta Radiol. 2020 Nov;61(11):1473-1483. doi: 10.1177/0284185120907246. Epub 2020 Mar 8. Acta Radiol. 2020. PMID: 32148066
-
18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.Eur Radiol. 2020 Jul;30(7):3641-3649. doi: 10.1007/s00330-020-06703-1. Epub 2020 Mar 3. Eur Radiol. 2020. PMID: 32125513
Cited by
-
Utility of preoperative dynamic magnetic resonance imaging of the pancreas in diagnosing tumor-forming pancreatitis that mimics pancreatic cancer: report of a case.Surg Today. 2010;40(1):76-8. doi: 10.1007/s00595-009-3992-y. Epub 2009 Dec 29. Surg Today. 2010. PMID: 20037846
-
Xanthogranulomatous pancreatitis mimicking a malignant cystic tumor of the pancreas: report of a case.Surg Today. 2011 Sep;41(9):1310-3. doi: 10.1007/s00595-010-4502-y. Epub 2011 Aug 26. Surg Today. 2011. PMID: 21874438
-
Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer.World J Gastroenterol. 2014 Nov 14;20(42):15580-9. doi: 10.3748/wjg.v20.i42.15580. World J Gastroenterol. 2014. PMID: 25400441 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical